I agree that this site is using cookies. You can find further informations here.
X
Korth‐Bradley, J.
115  results:
Search for persons X
?
1

Clinical experience with moroctocog alfa (AF‐CC) in younger..:

Rusen, L. ; Kavakli, K. ; Korth‐Bradley, J....
Haemophilia.  24 (2018)  4 - p. 604-610 , 2018
Link: https://doi.org/10.1111/..
 
?
2

Elucidation of Factor VIII Activity Pharmacokinetics: A Poo..:

Abrantes, JA ; Nielsen, EI ; Korth‐Bradley, J..
Clinical Pharmacology & Therapeutics.  102 (2017)  6 - p. 977-988 , 2017
Link: https://doi.org/10.1002/..
 
?
3

Once‐weekly prophylactic treatment vs. on‐demand treatment ..:

Kavakli, K. ; Smith, L. ; Kuliczkowski, K....
Haemophilia.  22 (2016)  3 - p. 381-388 , 2016
Link: https://doi.org/10.1111/..
 
?
4

Research Highlights:

Korth-Bradley, J. ; Bhattacharjee, K. R.
The Journal of Clinical Pharmacology.  47 (2007)  12 - p. 1587-1587 , 2007
Link: https://doi.org/10.1177/..
 
?
5

Use of pharmacokinetics in the coagulation factor treatment..:

Shapiro, A. D. ; Korth‐Bradley, J. ; Poon, M.‐C.
Haemophilia.  11 (2005)  6 - p. 571-582 , 2005
Link: https://doi.org/10.1111/..
 
?
6

Evaluating Possible Pharmacokinetic Interactions between To..:

Dowell, J.A. ; Korth-Bradley, J. ; Milisci, M....
Journal of Clinical Pharmacology.  41 (2001)  9 - p. 979-986 , 2001
Link: https://doi.org/10.1177/..
 
?
7

Pharmacokinetics of escalating doses of CCI-779 in combinat..:

Boni, J. ; Korth-Bradley, J. ; Punt, C.J.A....
European Journal of Cancer.  37 (2001)  - p. S68 , 2001
Link: https://doi.org/10.1016/..
 
?
8

A Randomized, Cross‐Over Study Investigating the Comparabil..:

Manners, Allison ; Korth‐Bradley, Joan ; Wajnrajch, Michael P.
Clinical Pharmacology in Drug Development.  , 2024
Link: https://doi.org/10.1002/..
 
?
9

THU170 Clinical And Immunological Response To Somatrogon In..:

Gupta, Rahul ; Khadgawat, Rajesh ; Rosenfeld, Ron G...
Journal of the Endocrine Society.  7 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1210/..
 
?
10

Once-weekly prophylaxis regimen of nonacog alfa in patients..:

Tortella, Bartholomew J. ; Carr, Marcus E. ; Rendo, Pablo...
Blood Coagulation & Fibrinolysis.  32 (2021)  3 - p. 180-185 , 2021
Link: https://doi.org/10.1097/..
 
?
11

Impact of treatment regimen with moroctocog alfa (AF‐CC) on..:

Smith, Mark P. ; Rupon, Jeremy ; Wali, Yasser...
Haemophilia.  26 (2020)  5 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
12

Assessment of the Effects of Age and Renal Function on Phar..:

McKeand, William ; Ermer, James ; Korth‐Bradley, Joan
Clinical Pharmacology in Drug Development.  7 (2018)  8 - p. 920-926 , 2018
Link: https://doi.org/10.1002/..
 
?
13

Performing and interpreting individual pharmacokinetic prof..:

Iorio, Alfonso ; Edginton, Andrea N. ; Blanchette, Victor...
Research and Practice in Thrombosis and Haemostasis.  2 (2018)  3 - p. 535-548 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Assessment of Relative Bioavailability of Moroctocog Alfa a..:

Korth‐Bradley, Joan ; Rupon, Jeremy ; Plotka, Anna..
Clinical and Translational Science.  11 (2018)  3 - p. 283-288 , 2018
Link: https://doi.org/10.1111/..
 
?
15

The impact of anti-drug antibodies on drug concentrations a..:

Moots, Robert J. ; Xavier, Ricardo M. ; Mok, Chi Chiu...
PLOS ONE.  12 (2017)  4 - p. e0175207 , 2017
Link: https://doi.org/10.1371/..
 
1-15